Selected research
Market Analysis & Forecast
Global DNA Microinjection Services Market Analysis and Forecast 2026-2032
Market perspective
The global DNA Microinjection Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for DNA Microinjection Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for DNA Microinjection Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for DNA Microinjection Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for DNA Microinjection Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of DNA Microinjection Services include Charles River, PolyGene, Taconic Biosciences, GenOway, Applied StemCell, JAX Mice, Biomodels, ModelOrg and Cyagen Biosciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for DNA Microinjection Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of DNA Microinjection Services, also provides the revenue of main regions and countries. Of the upcoming market potential for DNA Microinjection Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the DNA Microinjection Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DNA Microinjection Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for DNA Microinjection Services revenue, projected growth trends, production technology, application and end-user industry.
DNA Microinjection Services Segment by Company
Charles River
PolyGene
Taconic Biosciences
GenOway
Applied StemCell
JAX Mice
Biomodels
ModelOrg
Cyagen Biosciences
Biocytogen
GemPharmatech
Nanjing Aibei Biotechnology
Nanjing Senbega Biotechnology
Hangzhou Baiti Biotechnology
DNA Microinjection Services Segment by Type
Pronuclear Injection
Cytoplasmic Injection
Blastocyst Injection
Others
DNA Microinjection Services Segment by Application
Biomedicine
Agriculture & Animal Husbandry
Others
DNA Microinjection Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Microinjection Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Microinjection Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Microinjection Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of DNA Microinjection Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of DNA Microinjection Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA Microinjection Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pronuclear Injection
- Cytoplasmic Injection
- Blastocyst Injection
- Others
Applications
- Biomedicine
- Agriculture & Animal Husbandry
- Others
Companies covered
- Charles River
- PolyGene
- Taconic Biosciences
- GenOway
- Applied StemCell
- JAX Mice
- Biomodels
- ModelOrg
- Cyagen Biosciences
- Biocytogen
- GemPharmatech
- Nanjing Aibei Biotechnology
- Nanjing Senbega Biotechnology
- Hangzhou Baiti Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 DNA Microinjection Services Market by Type
- 1.2.1 Global DNA Microinjection Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Pronuclear Injection
- 1.2.3 Cytoplasmic Injection
- 1.2.4 Blastocyst Injection
- 1.2.5 Others
- 1.3 DNA Microinjection Services Market by Application
- 1.3.1 Global DNA Microinjection Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Biomedicine
- 1.3.3 Agriculture & Animal Husbandry
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 DNA Microinjection Services Market Dynamics
- 2.1 DNA Microinjection Services Industry Trends
- 2.2 DNA Microinjection Services Industry Drivers
- 2.3 DNA Microinjection Services Industry Opportunities and Challenges
- 2.4 DNA Microinjection Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global DNA Microinjection Services Market Perspective (2021-2032)
- 3.2 Global DNA Microinjection Services Growth Trends by Region
- 3.2.1 Global DNA Microinjection Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global DNA Microinjection Services Market Size by Region (2021-2026)
- 3.2.3 Global DNA Microinjection Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global DNA Microinjection Services Revenue by Players
- 4.1.1 Global DNA Microinjection Services Revenue by Players (2021-2026)
- 4.1.2 Global DNA Microinjection Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global DNA Microinjection Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global DNA Microinjection Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global DNA Microinjection Services Key Players Headquarters & Area Served
- 4.4 Global DNA Microinjection Services Players, Product Type & Application
- 4.5 Global DNA Microinjection Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global DNA Microinjection Services Market CR5 and HHI
- 4.6.3 2025 DNA Microinjection Services Tier 1, Tier 2, and Tier 3
5 DNA Microinjection Services Market Size by Type
- 5.1 Global DNA Microinjection Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global DNA Microinjection Services Revenue by Type (2021-2032)
- 5.3 Global DNA Microinjection Services Revenue Market Share by Type (2021-2032)
6 DNA Microinjection Services Market Size by Application
- 6.1 Global DNA Microinjection Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global DNA Microinjection Services Revenue by Application (2021-2032)
- 6.3 Global DNA Microinjection Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Charles River
- 7.1.1 Charles River Company Information
- 7.1.2 Charles River Business Overview
- 7.1.3 Charles River DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Charles River DNA Microinjection Services Product Portfolio
- 7.1.5 Charles River Recent Developments
- 7.2 PolyGene
- 7.2.1 PolyGene Company Information
- 7.2.2 PolyGene Business Overview
- 7.2.3 PolyGene DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.2.4 PolyGene DNA Microinjection Services Product Portfolio
- 7.2.5 PolyGene Recent Developments
- 7.3 Taconic Biosciences
- 7.3.1 Taconic Biosciences Company Information
- 7.3.2 Taconic Biosciences Business Overview
- 7.3.3 Taconic Biosciences DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.3.4 Taconic Biosciences DNA Microinjection Services Product Portfolio
- 7.3.5 Taconic Biosciences Recent Developments
- 7.4 GenOway
- 7.4.1 GenOway Company Information
- 7.4.2 GenOway Business Overview
- 7.4.3 GenOway DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.4.4 GenOway DNA Microinjection Services Product Portfolio
- 7.4.5 GenOway Recent Developments
- 7.5 Applied StemCell
- 7.5.1 Applied StemCell Company Information
- 7.5.2 Applied StemCell Business Overview
- 7.5.3 Applied StemCell DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.5.4 Applied StemCell DNA Microinjection Services Product Portfolio
- 7.5.5 Applied StemCell Recent Developments
- 7.6 JAX Mice
- 7.6.1 JAX Mice Company Information
- 7.6.2 JAX Mice Business Overview
- 7.6.3 JAX Mice DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.6.4 JAX Mice DNA Microinjection Services Product Portfolio
- 7.6.5 JAX Mice Recent Developments
- 7.7 Biomodels
- 7.7.1 Biomodels Company Information
- 7.7.2 Biomodels Business Overview
- 7.7.3 Biomodels DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.7.4 Biomodels DNA Microinjection Services Product Portfolio
- 7.7.5 Biomodels Recent Developments
- 7.8 ModelOrg
- 7.8.1 ModelOrg Company Information
- 7.8.2 ModelOrg Business Overview
- 7.8.3 ModelOrg DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.8.4 ModelOrg DNA Microinjection Services Product Portfolio
- 7.8.5 ModelOrg Recent Developments
- 7.9 Cyagen Biosciences
- 7.9.1 Cyagen Biosciences Company Information
- 7.9.2 Cyagen Biosciences Business Overview
- 7.9.3 Cyagen Biosciences DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Cyagen Biosciences DNA Microinjection Services Product Portfolio
- 7.9.5 Cyagen Biosciences Recent Developments
- 7.10 Biocytogen
- 7.10.1 Biocytogen Company Information
- 7.10.2 Biocytogen Business Overview
- 7.10.3 Biocytogen DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.10.4 Biocytogen DNA Microinjection Services Product Portfolio
- 7.10.5 Biocytogen Recent Developments
- 7.11 GemPharmatech
- 7.11.1 GemPharmatech Company Information
- 7.11.2 GemPharmatech Business Overview
- 7.11.3 GemPharmatech DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.11.4 GemPharmatech DNA Microinjection Services Product Portfolio
- 7.11.5 GemPharmatech Recent Developments
- 7.12 Nanjing Aibei Biotechnology
- 7.12.1 Nanjing Aibei Biotechnology Company Information
- 7.12.2 Nanjing Aibei Biotechnology Business Overview
- 7.12.3 Nanjing Aibei Biotechnology DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.12.4 Nanjing Aibei Biotechnology DNA Microinjection Services Product Portfolio
- 7.12.5 Nanjing Aibei Biotechnology Recent Developments
- 7.13 Nanjing Senbega Biotechnology
- 7.13.1 Nanjing Senbega Biotechnology Company Information
- 7.13.2 Nanjing Senbega Biotechnology Business Overview
- 7.13.3 Nanjing Senbega Biotechnology DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.13.4 Nanjing Senbega Biotechnology DNA Microinjection Services Product Portfolio
- 7.13.5 Nanjing Senbega Biotechnology Recent Developments
- 7.14 Hangzhou Baiti Biotechnology
- 7.14.1 Hangzhou Baiti Biotechnology Company Information
- 7.14.2 Hangzhou Baiti Biotechnology Business Overview
- 7.14.3 Hangzhou Baiti Biotechnology DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 7.14.4 Hangzhou Baiti Biotechnology DNA Microinjection Services Product Portfolio
- 7.14.5 Hangzhou Baiti Biotechnology Recent Developments
8 North America
- 8.1 North America DNA Microinjection Services Revenue (2021-2032)
- 8.2 North America DNA Microinjection Services Revenue by Type (2021-2032)
- 8.2.1 North America DNA Microinjection Services Revenue by Type (2021-2026)
- 8.2.2 North America DNA Microinjection Services Revenue by Type (2027-2032)
- 8.3 North America DNA Microinjection Services Revenue Share by Type (2021-2032)
- 8.4 North America DNA Microinjection Services Revenue by Application (2021-2032)
- 8.4.1 North America DNA Microinjection Services Revenue by Application (2021-2026)
- 8.4.2 North America DNA Microinjection Services Revenue by Application (2027-2032)
- 8.5 North America DNA Microinjection Services Revenue Share by Application (2021-2032)
- 8.6 North America DNA Microinjection Services Revenue by Country
- 8.6.1 North America DNA Microinjection Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America DNA Microinjection Services Revenue by Country (2021-2026)
- 8.6.3 North America DNA Microinjection Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe DNA Microinjection Services Revenue (2021-2032)
- 9.2 Europe DNA Microinjection Services Revenue by Type (2021-2032)
- 9.2.1 Europe DNA Microinjection Services Revenue by Type (2021-2026)
- 9.2.2 Europe DNA Microinjection Services Revenue by Type (2027-2032)
- 9.3 Europe DNA Microinjection Services Revenue Share by Type (2021-2032)
- 9.4 Europe DNA Microinjection Services Revenue by Application (2021-2032)
- 9.4.1 Europe DNA Microinjection Services Revenue by Application (2021-2026)
- 9.4.2 Europe DNA Microinjection Services Revenue by Application (2027-2032)
- 9.5 Europe DNA Microinjection Services Revenue Share by Application (2021-2032)
- 9.6 Europe DNA Microinjection Services Revenue by Country
- 9.6.1 Europe DNA Microinjection Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe DNA Microinjection Services Revenue by Country (2021-2026)
- 9.6.3 Europe DNA Microinjection Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China DNA Microinjection Services Revenue (2021-2032)
- 10.2 China DNA Microinjection Services Revenue by Type (2021-2032)
- 10.2.1 China DNA Microinjection Services Revenue by Type (2021-2026)
- 10.2.2 China DNA Microinjection Services Revenue by Type (2027-2032)
- 10.3 China DNA Microinjection Services Revenue Share by Type (2021-2032)
- 10.4 China DNA Microinjection Services Revenue by Application (2021-2032)
- 10.4.1 China DNA Microinjection Services Revenue by Application (2021-2026)
- 10.4.2 China DNA Microinjection Services Revenue by Application (2027-2032)
- 10.5 China DNA Microinjection Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia DNA Microinjection Services Revenue (2021-2032)
- 11.2 Asia DNA Microinjection Services Revenue by Type (2021-2032)
- 11.2.1 Asia DNA Microinjection Services Revenue by Type (2021-2026)
- 11.2.2 Asia DNA Microinjection Services Revenue by Type (2027-2032)
- 11.3 Asia DNA Microinjection Services Revenue Share by Type (2021-2032)
- 11.4 Asia DNA Microinjection Services Revenue by Application (2021-2032)
- 11.4.1 Asia DNA Microinjection Services Revenue by Application (2021-2026)
- 11.4.2 Asia DNA Microinjection Services Revenue by Application (2027-2032)
- 11.5 Asia DNA Microinjection Services Revenue Share by Application (2021-2032)
- 11.6 Asia DNA Microinjection Services Revenue by Country
- 11.6.1 Asia DNA Microinjection Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia DNA Microinjection Services Revenue by Country (2021-2026)
- 11.6.3 Asia DNA Microinjection Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA DNA Microinjection Services Revenue (2021-2032)
- 12.2 SAMEA DNA Microinjection Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA DNA Microinjection Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA DNA Microinjection Services Revenue by Type (2027-2032)
- 12.3 SAMEA DNA Microinjection Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA DNA Microinjection Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA DNA Microinjection Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA DNA Microinjection Services Revenue by Application (2027-2032)
- 12.5 SAMEA DNA Microinjection Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA DNA Microinjection Services Revenue by Country
- 12.6.1 SAMEA DNA Microinjection Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA DNA Microinjection Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA DNA Microinjection Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst